Research programme: CNS disoder therapeutics - Otsuka Pharmaceuticals/Schrodinger
Latest Information Update: 31 Mar 2023
Price :
$50 *
At a glance
- Originator Otsuka Pharmaceutical; Schrodinger
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research CNS disorders